Literature DB >> 31622686

Platin risk stratification algorithm with modified intradermal skin test protocol.

Amy S Levin1, Benjamin Slawski2, Carlos A Camargo3, Aleena Banerji2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31622686      PMCID： PMC7064419          DOI： 10.1016/j.jaip.2019.08.055

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  10 in total

1.  Platin chemotherapy hypersensitivity reactions: Expanding the scope of practice and improving care.

Authors:  Amy S Levin; Gita Bhattacharya; Kimberly Blumenthal; Carlos A Camargo; Aleena Banerji
Journal:  J Allergy Clin Immunol Pract       Date:  2018-12-19

2.  Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.

Authors:  Johnson T Wong; Morris Ling; Sarita Patil; Aleena Banerji; Aidan Long
Journal:  J Allergy Clin Immunol Pract       Date:  2013-11-01

3.  Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy.

Authors:  Alberta L Wang; Sarita U Patil; Aidan A Long; Aleena Banerji
Journal:  Ann Allergy Asthma Immunol       Date:  2015-08-19       Impact factor: 6.347

Review 4.  Skin Testing in the Evaluation and Management of Carboplatin-Related Hypersensitivity Reactions.

Authors:  Timothy Lax; Aidan Long; Aleena Banerji
Journal:  J Allergy Clin Immunol Pract       Date:  2015-10-01

5.  A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions.

Authors:  Sarita U Patil; Aidan A Long; Morris Ling; Michael T Wilson; Paul Hesterberg; Johnson T Wong; Aleena Banerji
Journal:  J Allergy Clin Immunol       Date:  2011-11-17       Impact factor: 10.793

6.  Simultaneous intradermal testing with hymenoptera venoms is safe and more efficient than sequential testing.

Authors:  B Strohmeier; W Aberer; D Bokanovic; P Komericki; G J Sturm
Journal:  Allergy       Date:  2013-02-14       Impact factor: 13.146

7.  Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.

Authors:  Mariana C Castells; Nichole M Tennant; David E Sloane; F Ida Hsu; Nora A Barrett; David I Hong; Tanya M Laidlaw; Henry J Legere; Samridhi N Nallamshetty; Ross I Palis; Jayanti J Rao; Suzanne T Berlin; Susana M Campos; Ursula A Matulonis
Journal:  J Allergy Clin Immunol       Date:  2008-05-27       Impact factor: 10.793

8.  Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.

Authors:  Aristides Polyzos; Nikolas Tsavaris; Hellen Gogas; John Souglakos; Lambros Vambakas; Nikolaos Vardakas; Kostas Polyzos; Christos Tsigris; Demetrios Mantas; Antonios Papachristodoulou; Nikolas Nikiteas; John G Karavokyros; Evangelos Felekouras; John Griniatsos; Athanasios Giannopoulos; Gregory Kouraklis
Journal:  Oncology       Date:  2008-11-26       Impact factor: 2.935

9.  Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.

Authors:  Paul E Hesterberg; Aleena Banerji; Eyal Oren; Richard T Penson; Carolyn N Krasner; Michael V Seiden; Johnson T Wong
Journal:  J Allergy Clin Immunol       Date:  2009-06       Impact factor: 10.793

10.  Venom allergy testing: is a graded approach necessary?

Authors:  Jaclyn A Quirt; Xia Wen; Jonathan Kim; Angel Jimenez Herrero; Harold L Kim
Journal:  Ann Allergy Asthma Immunol       Date:  2015-10-28       Impact factor: 6.347
  10 in total
  1 in total

Review 1.  Hypersensitivity Reactions to Platinum Agents and Taxanes.

Authors:  Lulu R Tsao; Fernanda D Young; Iris M Otani; Mariana C Castells
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-02       Impact factor: 10.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.